Education
About Us
Working with TipRanks
Follow Us
Panacea Biotec Limited (IN:PANACEABIO)
:PANACEABIO
Total Valuation
Panacea Biotec Limited has a market cap or net worth of ₹22.81B. The enterprise value is ₹22.44B.
Market Cap₹22.81B
Enterprise Value₹22.44B
Share Statistics
Panacea Biotec Limited has 61,250,744 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding61,250,744
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Panacea Biotec Limited’s return on equity (ROE) is -0.01 and return on invested capital (ROIC) is -6.58%.
Return on Equity (ROE)-0.01
Return on Assets (ROA)>-0.01
Return on Invested Capital (ROIC)-6.58%
Return on Capital Employed (ROCE)-0.07
Revenue Per Employee2.89M
Profits Per Employee-41.06K
Employee Count1,936
Asset Turnover0.43
Inventory Turnover0.93
Valuation Ratios
The current PE Ratio of Panacea Biotec Limited is ―. Panacea Biotec Limited’s PEG ratio is -0.53.
PE Ratio―
PS Ratio4.94
PB Ratio3.31
Price to Fair Value3.31
Price to FCF-35.56
Price to Operating Cash Flow0.00
PEG Ratio-0.53
Income Statement
In the last 12 months, Panacea Biotec Limited had revenue of 5.59B and earned -83.70M in profits. Earnings per share was -1.37.
Revenue5.59B
Gross Profit3.60B
Operating Income-607.20M
Pretax Income-79.50M
Net Income-83.70M
EBITDA307.40M
Earnings Per Share (EPS)-1.37
Cash Flow
In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.
Operating Cash Flow0.00
Free Cash Flow0.00
Free Cash Flow per Share0.00
Dividends & Yields
Panacea Biotec Limited pays an annual dividend of ₹0.75, resulting in a dividend yield of ―
Dividend Per Share₹0.75
Dividend Yield―
Payout Ratio―
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.71
52-Week Price Change5.39%
50-Day Moving Average368.00
200-Day Moving Average425.08
Relative Strength Index (RSI)48.99
Average Volume (3m)12.44K
Important Dates
Panacea Biotec Limited upcoming earnings date is Feb 13, 2026, TBA (Confirmed).
Last Earnings DateNov 14, 2025
Next Earnings DateFeb 13, 2026
Ex-Dividend Date―
Financial Position
Panacea Biotec Limited as a current ratio of 1.49, with Debt / Equity ratio of 2.77%
Current Ratio1.49
Quick Ratio0.90
Debt to Market Cap<0.01
Net Debt to EBITDA-1.95
Interest Coverage Ratio-15.65
Taxes
In the past 12 months, Panacea Biotec Limited has paid 7.70M in taxes.
Income Tax7.70M
Effective Tax Rate-0.10
Enterprise Valuation
Panacea Biotec Limited EV to EBITDA ratio is 87.91, with an EV/FCF ratio of -34.79.
EV to Sales4.83
EV to EBITDA87.91
EV to Free Cash Flow-34.79
EV to Operating Cash Flow-98.74
Balance Sheet
Panacea Biotec Limited has ₹1.10B in cash and marketable securities with ₹0.00 in debt, giving a net cash position of ₹1.10B billion.
Cash & Marketable Securities₹1.10B
Total Debt₹0.00
Net Cash₹1.10B
Net Cash Per Share₹17.98
Tangible Book Value Per Share₹129.04
Margins
Gross margin is 58.47%, with operating margin of -10.86%, and net profit margin of -1.50%.
Gross Margin58.47%
Operating Margin-10.86%
Pretax Margin-1.42%
Net Profit Margin-1.50%
EBITDA Margin5.50%
EBIT Margin-0.73%
Analyst Forecast
The average price target for Panacea Biotec Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast9.78%
EPS Growth Forecast50.78%